Arkolith/Insider Trading/CLOV/Form 4

Loengard Anna U

DirectorCLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) · full profile →Form 4 · filed Aug 14, 2025
Net Buying
Open-Market Buys
$69K
Open-Market Sells
$0
Net Open-Market Flow
$69K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 13, 2025Buy(P)15K$2.59$38K30K
Aug 13, 2025Buy(P)12K$2.60$31K28K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001801170-25-000221) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML